Company CEO’s Stock Sales Deemed Exempt From Statute’s Holding Requirement

Mealey's (April 13, 2022, 1:56 PM EDT) -- SAN FRANCISCO — A biotechnology company CEO’s sale of 2 million stock options awarded to him by the company’s board of directors less than six months earlier did not violate federal...

To view the full article, register now.